Weihao Wang et al.’s meta-analysis also demonstrated that combination therapy with GLP-1 and insulin can achieve ideal therapeutic effects on glycemic control, weight loss, and insulin dose reduction in patients with type 1 diabetes [34]. The gene discussed is INS; the disease is type 1 diabetes mellitus.